Sister to Juno’s liso-cel, JW’s relma-cel lands second-ever CAR-T approval in China

Juno may have stumbled its way to a distant third finish in the CD19 CAR-T race, but its joint venture in China is heading off to a thriving start.

JW Therapeutics, which took its name from co-founders Juno and WuXi AppTec, has scored the second-ever CAR-T...

Click to view original post